Introduction
Factor VII deficiency (or hypoproconvertinemia) is a rare autosomal-recessive bleeding disorder. More than 100 mutations have been identified in the Factor VII gene, located on chromosome 13 [1] . Its clinical manifestations are heterogeneous, ranging from miscellaneous minor bleeding to severe life-threatening hemorrhages and joint hemorrhages [2] . Here we present a case of congenital factor VII deficiency with chronic knee arthropathy.
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Case Report Mrs G.H, 15 years old, suffered from FVII deficiency, diagnosed during childhood. Her parents were consanguineous, and she had two brothers followed for the same bleeding disorder. The patient did not have any health insurance coverage. This girl experienced recurrent spontaneous hemarthrosis in her right knee starting at years of age (figure1). Hemarthroses lead to chronic pain and use of analgesics. Clinical examination found atrophy of quadriceps with a 7-centimeter decrease in the muscle perimeter, as compared to the left thigh. The affected knee was swollen and showed moderate stiffness. The prothrombin time was prolonged, and the prothrombin and proconvertin test was 10% of normal. The activated partial thromboplastin time and the Stypven-cephalin clotting time were normal. The factor VII level was 1.4% of normal.
Plain radiographs showed osteoporosis, widening of the epichondral notch of the knee, epiphyseal overgrowth, bone cysts, joint space irregularity and global narrowing (figure 2). Ultrasonography of the knee found synovial hypertrophy associated to hypoechogenic effusion in the quadriceps recesses ( figure 3 ). The diagnosis of chronic arthropathy secondary to factor VII deficiency was retained. Our patient has had an intra-articular injection of triamcinolone hexacetonide following fresh frozen plasma transfusion. Decreases in swelling and joint stiffness were recorded after rehabilitation. Furthermore, our patient expressed improvement of the Lesquene and the scores. Discussion Congenital factor VII deficiency is a rare autosomalrecessive bleeding disorder, accounting for one symptomatic individual per 500,000 [1, 2] . Frequency is higher in countries where consanguineous marriage is more common, as in the case of Morocco. This inherited coagulation disorder is the only congenital bleeding disorder characterized by isolated prolonged prothrombin time, as observed in our case [3] . Clinical heterogeneity is the hallmark of this hemorrhagic disorder [2, 3] . Bleeding manifestations and clinical findings vary widely, ranging from asymptomatic subjects to patients with hemorrhages that may cause significant handicaps [2, 4] . It should be noted that, because of the poor correlation between FVII levels and the bleeding tendency, FVIIC levels cannot be used to distinguish classes of severity [5] . Thus, severity of FVII deficiency is classified on a clinical basis. Since chronic arthropathy has occurred in our patient, her FVII deficiency is qualified as severe. As in hemophilia, recurrent hemarthrosis leads to chronic arthropathy, a source of functional disability [6] . Although hemarthrosis is less common than hemophilia, the characteristics of joint destruction are similar in the two conditions [4, 6] . Management of factor VII deficiency bleeding disorder, in terms of substitution therapy and therapy schedules, is not yet optimal [7] . Treatments used for the treatment of FVII deficiency involve FVII replacement therapy using fresh frozen plasma, prothrombin complex concentrates (PCCs), plasma FVII concentrates and, more recently, intravenous administration of recombinant FVIIa. Management of arthropathy could be similar to that in hemophilia cases. Bleeding into joints requires prophylactic replacement therapy. Besides surgical options, two basic types of synoviorthesis could be used in chronic arthropathy: chemical and radioactive. The materials most commonly used for chemical synovectomy are osmic acid, rifampicin, and oxytetracycline clorhydrate [6, 7] . However, intra-articular injections of steroids have been used to decrease pain and inflammation in patients with chronic synovitis, and may be useful as a palliative measure [8] . Evolution in our case is quiet satisfactory, at least regarding pain and functional status.
Conclusion
Our case illustrates an exceptional etiology of chronic arthropathy. Less known than hemophilia, factor VII deficiency should be suspected in cases of prolonged prothrombin time with normal partial thromboplastin time. Bleeding into the joints requires prophylactic replacement therapy. Intra-articular injection of corticosteroids may be useful as a palliative measure for pain and inflammation, particularly in countries with limited resources.
